Serologic imprint of dengue virus in urban Haiti: Characterization of humoral immunity to dengue in infants and young children

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 4, 2011, Pages 630-636

  Rioth, Meghan ^a   Beauharnais, Carole Anne ^b   Noel, Francine ^b   Ikizler, Mine R ^c   Mehta, Sapna ^a   Zhu, Yuwei ^a   Long, Carole A ^d   Pape, Jean W ^b   Wright, Peter F ^e  

^a VANDERBILT UNIVERSITY   (United States)

^b Department of Adolescent Medicine   (Haïti)

^c Division of Infectious Diseases   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; PROTOZOON ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CHILD; CHILDHOOD DISEASE; CROSS REACTION; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENDEMIC DISEASE; FEMALE; GROUPS BY AGE; HAITI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMORAL IMMUNITY; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PLAQUE REDUCTION NEUTRALIZATION ASSAY; PRESCHOOL CHILD; SERODIAGNOSIS; SEROPREVALENCE; URBAN AREA; VIRUS IMMUNITY; BLOOD; CLASSIFICATION; DENGUE VIRUS; IMMUNOLOGY; SEROTYPING; URBAN POPULATION;

DENGUE VIRUS;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; IMMUNITY, HUMORAL; INFANT; MALE; SEROTYPING; URBAN POPULATION;

EID: 79957982371     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0323     Document Type: Article

References (31)

1. Halstead SB, 2002. Dengue. Curr Opin Infect Dis 15: 471-476.
2. Guzman MG, Kouri G, 2008. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans R Soc Trop Med Hyg 102: 522-523.
3. Rico-Hesse R, 2010. Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol 338: 45-55.
4. Kanakaratne N, Wahala WM, Messer WB, Tissera HA, Shahani A, Abeysinghe N, de-Silva AM, Gunasekera M, 2009. Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis 15: 192-199.
5. Guzman MG, Sierra B, Kouri G, Farrar J, Simmons C, 2010. Host and virus determinants of susceptibility and dengue disease severity. Hanley KA, Weaver SC, eds. Frontiers in Dengue Virus Research. Norfolk, United Kingdom: Caister Academic Press, 79-102.
6. Rossi CA, Drabick JJ, Gambel JM, Sun W, Lewis TE, Henchal EA, 1998. Laboratory diagnosis of acute dengue fever during the United Nations Mission in Haiti, 1995-1996. Am J Trop Med Hyg 59: 275-278.
7. Trofa AF, DeFraites RF, Smoak BL, Kanesa-thasan N, King AD, Burrous JM, MacArthy PO, Rossi C, Hoke CH Jr, 1997. Dengue fever in US military personnel in Haiti. JAMA 277: 1546-1548. (Pubitemid 27213304)
8. Ventura AK, Ehrenkranz NJ, 1976. Endemic dengue virus infection in Hispaniola. I. Haiti. J Infect Dis 134: 436-441.
9. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, Kanesa-Thasan N, Hayes CG, Watts DM, 2001. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 65: 180-183. (Pubitemid 32847807)
10. de la C Sierra B, Kourí G, Guzmán MG, 2007. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533-542. (Pubitemid 46363592)
11. WHO Statistical Information System (WHOSIS), 2006. Probability of Dying Aged < 5 Years per 1000 Live Births (Under-Five Mortality Rate). Available at: http://www.who.int/whosis/indicators/ 2007MortChild/en/index.html. Accessed April 1, 2010.
12. Noel F, Wright PF, Bois G, Deschamps MM, de Matteis P, Cassangnol R, Thimothee M, Celestin K, Vaz L, Bradshaw JA, Brignoli E, Zhu Y, Johnson WD, Fitzgerald D, Pape JW, 2006. Contribution of bacterial sepsis to morbidity in infants born to HIV-infected Haitian mothers. J Acquir Immune Defic Syndr 43: 313-319. (Pubitemid 44674011)
13. Russell PK, Nisalak A, Sukhavachana P, Vivona S, 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99: 285-290.
14. Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, Perreault JR, Thumar B, Men R, Lai CJ, Elkins WR, Chanock RM, Murphy BR, Whitehead SS, 2001. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3?-untranslated region. Am J Trop Med Hyg 65: 405-413. (Pubitemid 33134570)
15. Wright PF, Durbin AP, Whitehead SS, Ikizler MR, Henderson S, Blaney JE, Thumar B, Ankrah S, Rock MT, McKinney BA, Murphy BR, Schmidt AC, 2009. Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers. Am J Trop Med Hyg 81: 834-841.
16. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP, 2009. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am J Trop Med Hyg 81: 825-833.
17. Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, Lanar DE, Remarque E, Ross A, Williams TN, Mwambingu G, Lowe B, Conway DJ, Marsh K, 2004. Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23: 718-728. (Pubitemid 39473204)
18. Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, Miller LH, Martin LB, Pierce MA, Ellis RD, Mullen GE, Long CA, 2009. Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting Plasmodium falciparum growth, as determined by the in vitro growth inhibition assay. Clin Vaccine Immunol 16: 963-968.
19. Simmons CP, Chau TN, Thuy TT, Tuan NM, Hoang DM, Thien NT, Lien le B, Quy NT, Hieu NT, Hien TT, McElnea C, Young P, Whitehead S, Hung NT, Farrar J, 2007. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 196: 416-424. (Pubitemid 47093892)
20. Noel F, Mehta S, Zhu Y, Rouzier Pde M, Marcelin A, Shi JR, Nolte C, Severe L, Deschamps MM, Fitzgerald DW, Johnson WD, Wright PF, Pape JW, 2008. Improving outcomes in infants of HIV-infected women in a developing country setting. PLoS ONE 3: e3723.
21. Chau TN, Quyen NT, Thuy TT, Tuan NM, Hoang DM, Dung NT, Lien le B, Quy NT, Hieu NT, Hieu LT, Hien TT, Hung NT, Farrar J, Simmons CP, 2008. Dengue in Vietnamese infants- results of infection-enhancement assays correlate with agerelated disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis 198: 516-524.
22. Chaturvedi U, Nagar R, Shrivastava R, 2006. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47: 155-166. (Pubitemid 43881735)
23. Lenhart A, Orelus N, Maskill R, Alexander N, Streit T, McCall PJ, 2008. Insecticide-treated bednets to control dengue vectors: preliminary evidence from a controlled trial in Haiti. Trop Med Int Health 13: 56-67. (Pubitemid 351271382)
24. Pengsaa K, Limkittikul K, Luxemburger C, Yoksan S, Chambonneau L, Ariyasriwatana C, Lapphra K, Chanthavanich P, Lang J, Sabchareon A, 2008. Age-specific prevalence of dengue antibodies in Bangkok infants and children. Pediatr Infect Dis J 27: 461-463.
25. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, Saborío S, Hammond SN, Nuñez A, Avilés W, Henn MR, Holmes EC, Gordon A, Coloma J, Kuan G, Harris E, 2010. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201: 5-14.
26. Anonymous, 1998. Asia: dengue fever, a man-made disease. The Economist 347(8066): 538.
27. Bonnlander H, Rossignol AM, Rossignol PA, 1994. Malaria in central Haiti: a hospital-based retrospective study, 1982-1986 and 1988-1991. Bull Pan Am Health Organ 28: 9-16.
28. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, Saborío S, Hammond SN, Nuñez A, Avilés W, Henn MR, Holmes EC, Gordon A, Coloma J, Kuan G, Harris E, 2010. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201: 5-14.
29. Kuan G, Gordon A, Avilés W, Ortega O, Hammond SN, Elizondo D, Nuñez A, Coloma J, Balmaseda A, Harris E, 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170: 120-129.
30. Lenhart A, Orelus N, Maskill R, Alexander N, Streit T, McCall PJ. 2008. Insecticide-treated bednets to control dengue vectors: preliminary evidence from a controlled trial in Haiti. Trop Med Int Health 13: 56-67. (Pubitemid 351271382)
31. Climate Information for Haiti. Available at: http://www.climatetemp .info/haiti/.